Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24645 | 305 | 28.6 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
3501 | 2 | AMBROXOL//ERDOSTEINE//N ACETYLCYSTEINE | 1436 |
24645 | 1 | ERDOSTEINE//S CARBOXYMETHYL L CYSTEINE//FUDOSTEINE | 305 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ERDOSTEINE | authKW | 1521709 | 12% | 40% | 38 |
2 | S CARBOXYMETHYL L CYSTEINE | authKW | 939966 | 4% | 72% | 13 |
3 | FUDOSTEINE | authKW | 901039 | 3% | 100% | 9 |
4 | CARBOCISTEINE | authKW | 435273 | 3% | 43% | 10 |
5 | PHENYLALANINE 4 MONOOXYGENASE | authKW | 417146 | 2% | 83% | 5 |
6 | CARBOCYSTEINE | authKW | 350397 | 2% | 50% | 7 |
7 | CARBOCYSTEINE LYSINE SALT MONOHYDRATE | authKW | 300346 | 1% | 100% | 3 |
8 | CAS 84611 23 4 | authKW | 300346 | 1% | 100% | 3 |
9 | PHENYLALANINE MONOOXYGENASE | authKW | 300346 | 1% | 100% | 3 |
10 | DOMIODOL | authKW | 200231 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2044 | 48% | 0% | 146 |
2 | Respiratory System | 514 | 11% | 0% | 34 |
3 | Toxicology | 160 | 8% | 0% | 23 |
4 | Chemistry, Analytical | 129 | 10% | 0% | 31 |
5 | Chemistry, Medicinal | 82 | 6% | 0% | 17 |
6 | Biochemical Research Methods | 59 | 6% | 0% | 17 |
7 | Rheumatology | 25 | 2% | 0% | 6 |
8 | Medicine, General & Internal | 25 | 6% | 0% | 18 |
9 | Medicine, Research & Experimental | 20 | 4% | 0% | 13 |
10 | Clinical Neurology | 8 | 4% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 3AOBA KU | 100115 | 0% | 100% | 1 |
2 | DEPY TRANSLAT CLIN ONCOL | 100115 | 0% | 100% | 1 |
3 | HH NORDHESSEN | 100115 | 0% | 100% | 1 |
4 | MED SURG AGOSTINO GEMELLI GEN SURG | 100115 | 0% | 100% | 1 |
5 | MED SURG AGOSTINO GEMELLI THER Y CLIN | 100115 | 0% | 100% | 1 |
6 | PHARMACEUT PHARMACOL SCI PHARMACEUT ANALYS | 100115 | 0% | 100% | 1 |
7 | PHARMACEUTICAL SCI | 100115 | 0% | 100% | 1 |
8 | QUAL ASSURANCE TECH PHARMACEUT CHEM | 100115 | 0% | 100% | 1 |
9 | UNITA FUNZ PNEUMOL RIABILITAZ P | 100115 | 0% | 100% | 1 |
10 | VETERIN SA | 100115 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FOLIA PHARMACOLOGICA JAPONICA | 7368 | 3% | 1% | 9 |
2 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 3098 | 4% | 0% | 11 |
3 | XENOBIOTICA | 2574 | 3% | 0% | 10 |
4 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 2433 | 2% | 0% | 6 |
5 | COMPLEMENT AND INFLAMMATION | 1219 | 0% | 1% | 1 |
6 | RESPIRATION | 1000 | 2% | 0% | 6 |
7 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 863 | 1% | 0% | 4 |
8 | JAPANESE JOURNAL OF PHARMACOLOGY | 814 | 2% | 0% | 6 |
9 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 782 | 1% | 0% | 4 |
10 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 756 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERDOSTEINE | 1521709 | 12% | 40% | 38 | Search ERDOSTEINE | Search ERDOSTEINE |
2 | S CARBOXYMETHYL L CYSTEINE | 939966 | 4% | 72% | 13 | Search S+CARBOXYMETHYL+L+CYSTEINE | Search S+CARBOXYMETHYL+L+CYSTEINE |
3 | FUDOSTEINE | 901039 | 3% | 100% | 9 | Search FUDOSTEINE | Search FUDOSTEINE |
4 | CARBOCISTEINE | 435273 | 3% | 43% | 10 | Search CARBOCISTEINE | Search CARBOCISTEINE |
5 | PHENYLALANINE 4 MONOOXYGENASE | 417146 | 2% | 83% | 5 | Search PHENYLALANINE+4+MONOOXYGENASE | Search PHENYLALANINE+4+MONOOXYGENASE |
6 | CARBOCYSTEINE | 350397 | 2% | 50% | 7 | Search CARBOCYSTEINE | Search CARBOCYSTEINE |
7 | CARBOCYSTEINE LYSINE SALT MONOHYDRATE | 300346 | 1% | 100% | 3 | Search CARBOCYSTEINE+LYSINE+SALT+MONOHYDRATE | Search CARBOCYSTEINE+LYSINE+SALT+MONOHYDRATE |
8 | CAS 84611 23 4 | 300346 | 1% | 100% | 3 | Search CAS+84611+23+4 | Search CAS+84611+23+4 |
9 | PHENYLALANINE MONOOXYGENASE | 300346 | 1% | 100% | 3 | Search PHENYLALANINE+MONOOXYGENASE | Search PHENYLALANINE+MONOOXYGENASE |
10 | DOMIODOL | 200231 | 1% | 100% | 2 | Search DOMIODOL | Search DOMIODOL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MITCHELL, SC , STEVENTON, GB , (2012) S-CARBOXYMETHYL-L-CYSTEINE.DRUG METABOLISM REVIEWS. VOL. 44. ISSUE 2. P. 129 -147 | 50 | 53% | 3 |
2 | STEVENTON, GB , (1998) A METHODOLOGICAL AND METABOLITE IDENTIFICATION STUDY OF THE METABOLISM OF S-CARBOXYMETHYL-L-CYSTEINE IN MAN.CHROMATOGRAPHIA. VOL. 48. ISSUE 7-8. P. 561-568 | 18 | 95% | 8 |
3 | FAN, PC , REN, J , MA, HP , JING, LL , MA, J , JIA, ZP , (2014) LIQUID CHROMATOGRAPHY TANDEM MASS/MASS SPECTROMETRY FOR THE QUANTIFICATION OF FUDOSTEINE IN HUMAN SERUM WITHOUT PRECOLUMN DERIVATIZATION.IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH. VOL. 13. ISSUE 2. P. 441-447 | 9 | 100% | 0 |
4 | PANAGOPOULOS, P , FORBES, B , MITCHELL, SC , STEVENTON, GB , (2010) THE PHARMACOKINETICS OF ORALLY ADMINISTERED S-CARBOXYMETHYL-L-CYSTEINE IN THE DOG, CALF AND SHEEP.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 39. ISSUE 4. P. 219-223 | 12 | 80% | 1 |
5 | STEVENTON, GB , (1999) DIURNAL VARIATION IN THE METABOLISM OF S-CARBOXYMETHYL-L-CYSTEINE IN HUMANS.DRUG METABOLISM AND DISPOSITION. VOL. 27. ISSUE 9. P. 1092-1097 | 15 | 83% | 22 |
6 | BI, HC , ZHAO, LZ , ZHONG, GP , ZHOU, SF , LI, B , DENG, Y , CHEN, X , HUANG, M , (2006) HIGH-THROUGHPUT DETERMINATION OF CARBOCYSTEINE IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY: APPLICATION TO A BIOEQUIVALENCE STUDY OF TWO FORMULATIONS IN HEALTHY VOLUNTEERS.RAPID COMMUNICATIONS IN MASS SPECTROMETRY. VOL. 20. ISSUE 7. P. 1153-1160 | 13 | 76% | 8 |
7 | PANAGOPOULOS, P , MITCHELL, SC , STEVENTON, GB , (2015) S-CARBOXYMETHYL-L-CYSTEINE AND IT (R/S)-S-OXIDES IN BEAGLE DOG PLASMA AND HEPATIC CYTOSOL.XENOBIOTICA. VOL. 45. ISSUE 12. P. 1047 -1053 | 16 | 50% | 0 |
8 | DAL NEGRO, RW , (2008) ERDOSTEINE: ANTITUSSIVE AND ANTI-INFLAMMATORY EFFECTS.LUNG. VOL. 186. ISSUE . P. S70-S73 | 10 | 91% | 12 |
9 | MORETTI, M , (2009) ERDOSTEINE: ITS RELEVANCE IN COPD TREATMENT.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 3. P. 333-343 | 15 | 58% | 9 |
10 | MCFADDEN, SA , (1996) PHENOTYPIC VARIATION IN XENOBIOTIC METABOLISM AND ADVERSE ENVIRONMENTAL RESPONSE: FOCUS ON SULFUR-DEPENDENT DETOXIFICATION PATHWAYS.TOXICOLOGY. VOL. 111. ISSUE 1-3. P. 43-65 | 30 | 42% | 20 |
Classes with closest relation at Level 1 |